Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hypoxia Inducible Factor 1 Alpha Inhibitor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hypoxia Inducible Factor 1 Alpha Inhibitormarket, defines the market attractiveness level of Hypoxia Inducible Factor 1 Alpha Inhibitor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hypoxia Inducible Factor 1 Alpha Inhibitor industry, describes the types of Hypoxia Inducible Factor 1 Alpha Inhibitor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hypoxia Inducible Factor 1 Alpha Inhibitor market and the development prospects and opportunities of Hypoxia Inducible Factor 1 Alpha Inhibitor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hypoxia Inducible Factor 1 Alpha Inhibitor market in Chapter 13.
By Player:
F Hoffmann-La Roche Ltd
Sorrento Therapeutics Inc
Peloton Therapeutics Inc
OncoImmune Inc
RXi Pharmaceuticals Corporation
Transcriptogen Ltd
InterMed Discovery GmbH
CASI Pharmaceuticals Inc
Cerulean Pharma Inc
Aileron Therapeutics Inc
Vascular Biogenics Ltd
By Type:
BC-001
CASI-2ME2
CRLX-101
Others
By End-User:
Solid Tumor
Acute Myelocytic Leukemia
Colorectal Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hypoxia Inducible Factor 1 Alpha Inhibitor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hypoxia Inducible Factor 1 Alpha Inhibitor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis and Outlook to 2022
-
7.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
-
7.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
-
7.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
-
7.4 China Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
-
7.5 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
-
7.6 India Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
-
7.7 South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption (2017-2022)
8 Region and Country-wise Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis and Outlook to 2028
-
8.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
-
8.2 United States Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
-
8.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
-
8.4 China Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
-
8.5 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
-
8.6 India Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
-
8.7 South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast (2022-2028)
9 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Outlook by Types and Applications to 2022
-
9.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BC-001 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CASI-2ME2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CRLX-101 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Acute Myelocytic Leukemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Outlook by Types and Applications to 2028
-
10.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BC-001 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CASI-2ME2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CRLX-101 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Acute Myelocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Competitive Analysis
-
14.1 F Hoffmann-La Roche Ltd
-
14.1.1 F Hoffmann-La Roche Ltd Company Details
-
14.1.2 F Hoffmann-La Roche Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 F Hoffmann-La Roche Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.2 Sorrento Therapeutics Inc
-
14.2.1 Sorrento Therapeutics Inc Company Details
-
14.2.2 Sorrento Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sorrento Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.3 Peloton Therapeutics Inc
-
14.3.1 Peloton Therapeutics Inc Company Details
-
14.3.2 Peloton Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Peloton Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.4 OncoImmune Inc
-
14.4.1 OncoImmune Inc Company Details
-
14.4.2 OncoImmune Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 OncoImmune Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.5 RXi Pharmaceuticals Corporation
-
14.5.1 RXi Pharmaceuticals Corporation Company Details
-
14.5.2 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.6 Transcriptogen Ltd
-
14.6.1 Transcriptogen Ltd Company Details
-
14.6.2 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.7 InterMed Discovery GmbH
-
14.7.1 InterMed Discovery GmbH Company Details
-
14.7.2 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.8 CASI Pharmaceuticals Inc
-
14.8.1 CASI Pharmaceuticals Inc Company Details
-
14.8.2 CASI Pharmaceuticals Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 CASI Pharmaceuticals Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.9 Cerulean Pharma Inc
-
14.9.1 Cerulean Pharma Inc Company Details
-
14.9.2 Cerulean Pharma Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Cerulean Pharma Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.10 Aileron Therapeutics Inc
-
14.10.1 Aileron Therapeutics Inc Company Details
-
14.10.2 Aileron Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Aileron Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
14.11 Vascular Biogenics Ltd
-
14.11.1 Vascular Biogenics Ltd Company Details
-
14.11.2 Vascular Biogenics Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Vascular Biogenics Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hypoxia Inducible Factor 1 Alpha Inhibitor
-
Figure Hypoxia Inducible Factor 1 Alpha Inhibitor Picture
-
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Country (2017-2022)
-
Figure United States Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate (2017-2022)
-
Table Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast by Country (2022-2028)
-
Figure United States Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BC-001 Consumption and Growth Rate (2017-2022)
-
Figure Global CASI-2ME2 Consumption and Growth Rate (2017-2022)
-
Figure Global CRLX-101 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Myelocytic Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global BC-001 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CASI-2ME2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CRLX-101 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Myelocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hypoxia Inducible Factor 1 Alpha Inhibitor Export by Region (Top 5 Countries) (2017-2028)
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table Sorrento Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table Peloton Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Peloton Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Peloton Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table OncoImmune Inc (Foundation Year, Company Profile and etc.)
-
Table OncoImmune Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoImmune Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table RXi Pharmaceuticals Corporation (Foundation Year, Company Profile and etc.)
-
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table Transcriptogen Ltd (Foundation Year, Company Profile and etc.)
-
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table InterMed Discovery GmbH (Foundation Year, Company Profile and etc.)
-
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table CASI Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table CASI Pharmaceuticals Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table CASI Pharmaceuticals Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table Cerulean Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Cerulean Pharma Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cerulean Pharma Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table Aileron Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Aileron Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aileron Therapeutics Inc Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
Table Vascular Biogenics Ltd (Foundation Year, Company Profile and etc.)
-
Table Vascular Biogenics Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vascular Biogenics Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product and Service
-
